Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

TTD hair is brittle due to fewer sulfur amino acids and unstable disulfide bonds.

CRISPR/Cas9 and prime editing can potentially fix skin disorder genes safely and effectively.

Low TRPS1 expression in skin and hair cells is linked to hair problems in Trichorhinophalangeal syndrome.

Low-level laser therapy can help with inflammation but isn't widely accepted yet.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

The treatment was not recommended due to limited effectiveness and significant side effects.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

The thulium laser and PDRN injections effectively improved hair thickness in patients with pattern hair loss.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Thymoma-associated multiorgan autoimmunity can cause liver damage and affects multiple organs, with limited treatment options and a generally poor prognosis.

BTNL2 helps protect hair follicles from immune attacks.

A mutation in the iRhom2 gene causes hairless mice due to abnormal hair follicle development.

Low Level Laser Therapy can promote hair growth.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Noncoding dsRNA helps produce exosomes that aid in skin regeneration.

Spanlastics effectively deliver Rizatriptan Benzoate with high efficiency and controlled release.

Researchers made a detailed map of gene activity for different parts of human hair follicles to help create targeted hair disorder treatments.

Thallium is highly toxic, causing severe health issues, and Prussian blue is the best antidote.

Low-level laser therapy may help uninfected cells but has different effects on coronavirus-infected cells.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Deleting the Trf1 protein in mice is safe and may help prevent cancer without major side effects.

HOTTIP and miR-10b contribute to glioma therapy resistance by affecting cell behavior, suggesting they could be targets for treatment.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

The enzyme Rand protease works well for leather dehairing and its stability is important, with Leu75 playing a key role.

Trans-esophageal echocardiography is crucial for accurately diagnosing heart issues in lupus patients.

Some drugs for inflammation may cause psoriasis-like hair loss.